Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 210

1.

Temporal trends in the incidence of surgical site infections in patients undergoing coronary artery bypass graft surgery: a population-based cohort study, 1993 to 2008.

Alasmari FA, Tleyjeh IM, Riaz M, Greason KL, Berbari EF, Virk A, Baddour LM.

Mayo Clin Proc. 2012 Nov;87(11):1054-61. doi: 10.1016/j.mayocp.2012.05.026.

2.

Results of a comprehensive infection control program for reducing surgical-site infections in coronary artery bypass surgery.

McConkey SJ, L'Ecuyer PB, Murphy DM, Leet TL, Sundt TM, Fraser VJ.

Infect Control Hosp Epidemiol. 1999 Aug;20(8):533-8.

PMID:
10466552
3.

Surgical-site infection rates and risk factor analysis in coronary artery bypass graft surgery.

Harrington G, Russo P, Spelman D, Borrell S, Watson K, Barr W, Martin R, Edmonds D, Cocks J, Greenbough J, Lowe J, Randle L, Castell J, Browne E, Bellis K, Aberline M.

Infect Control Hosp Epidemiol. 2004 Jun;25(6):472-6.

PMID:
15242194
4.

Validation of coronary artery bypass graft surgical site infection surveillance data from a statewide surveillance system in Australia.

Friedman ND, Russo PL, Bull AL, Richards MJ, Kelly H.

Infect Control Hosp Epidemiol. 2007 Jul;28(7):812-7. Epub 2007 May 17.

PMID:
17564983
5.

Predictive factors for surgical site infection in general surgery.

Haridas M, Malangoni MA.

Surgery. 2008 Oct;144(4):496-501; discussion 501-3. doi: 10.1016/j.surg.2008.06.001.

PMID:
18847631
6.

An alternative scoring system to predict risk for surgical site infection complicating coronary artery bypass graft surgery.

Friedman ND, Bull AL, Russo PL, Leder K, Reid C, Billah B, Marasco S, McBryde E, Richards MJ.

Infect Control Hosp Epidemiol. 2007 Oct;28(10):1162-8. Epub 2007 Aug 3.

PMID:
17828693
7.

Association between statins and infections after coronary artery bypass grafting.

Kayani WT, Bandeali SJ, Lee VV, Elayda M, Khan A, Nambi V, Jneid H, Alam M, Wilson JM, Huang HD, Birnbaum Y, Ballantyne CM, Virani SS.

Int J Cardiol. 2013 Sep 20;168(1):117-20. doi: 10.1016/j.ijcard.2012.09.060. Epub 2012 Oct 7.

PMID:
23046597
8.

Validating a 3-point prediction rule for surgical site infection after coronary artery bypass surgery.

Chen LF, Anderson DJ, Kaye KS, Sexton DJ.

Infect Control Hosp Epidemiol. 2010 Jan;31(1):64-8. doi: 10.1086/649019.

PMID:
19911975
9.

Increase in the rate of sternal surgical site infection after coronary artery bypass graft: a marker of higher severity of illness.

Fakih MG, Sharma M, Khatib R, Berriel-Cass D, Meisner S, Harrington S, Saravolatz L.

Infect Control Hosp Epidemiol. 2007 Jun;28(6):655-60. Epub 2007 May 10.

PMID:
17520536
10.

Reduction in surgical site infection in patients treated with microbial sealant prior to coronary artery bypass graft surgery: a case-control study.

Dohmen PM, Gabbieri D, Weymann A, Linneweber J, Konertz W.

J Hosp Infect. 2009 Jun;72(2):119-26. doi: 10.1016/j.jhin.2009.02.005. Epub 2009 Mar 13.

PMID:
19285360
11.

The standardized incidence ratio as a reliable tool for surgical site infection surveillance.

Rioux C, Grandbastien B, Astagneau P.

Infect Control Hosp Epidemiol. 2006 Aug;27(8):817-24. Epub 2006 Jul 24.

PMID:
16874641
12.

Patient outcomes associated with 2-octyl cyanoacrylate topical skin adhesive in coronary artery bypass graft surgery.

Fraeman KH, Reynolds MW, Vaughn BB, Hart JC.

Surg Infect (Larchmt). 2011 Aug;12(4):307-16. doi: 10.1089/sur.2010.062.

PMID:
21859334
13.

Sternal surgical-site infection following coronary artery bypass graft: prevalence, microbiology, and complications during a 42-month period.

Sharma M, Berriel-Cass D, Baran J Jr.

Infect Control Hosp Epidemiol. 2004 Jun;25(6):468-71.

PMID:
15242193
14.

Use of Medicare claims to rank hospitals by surgical site infection risk following coronary artery bypass graft surgery.

Huang SS, Placzek H, Livingston J, Ma A, Onufrak F, Lankiewicz J, Kleinman K, Bratzler D, Olsen MA, Lyles R, Khan Y, Wright P, Yokoe DS, Fraser VJ, Weinstein RA, Stevenson K, Hooper D, Vostok J, Datta R, Nsa W, Platt R.

Infect Control Hosp Epidemiol. 2011 Aug;32(8):775-83. doi: 10.1086/660874.

PMID:
21768761
15.

National surveillance of surgical site infections after coronary artery bypass grafting in Norway: incidence and risk factors.

Berg TC, Kjørstad KE, Akselsen PE, Seim BE, Løwer HL, Stenvik MN, Sorknes NK, Eriksen HM.

Eur J Cardiothorac Surg. 2011 Dec;40(6):1291-7. doi: 10.1016/j.ejcts.2011.02.038. Epub 2011 Mar 30.

PMID:
21450472
16.

Interrupted time series analysis of vancomycin compared to cefuroxime for surgical prophylaxis in patients undergoing cardiac surgery.

Garey KW, Lai D, Dao-Tran TK, Gentry LO, Hwang LY, Davis BR.

Antimicrob Agents Chemother. 2008 Feb;52(2):446-51. Epub 2007 Nov 19.

17.

Adjuvant vancomycin for antibiotic prophylaxis and risk of Clostridium difficile infection after coronary artery bypass graft surgery.

Bateman BT, Rassen JA, Schneeweiss S, Bykov K, Franklin JM, Gagne JJ, Polinski JM, Liu J, Kulik A, Fischer MA, Choudhry NK.

J Thorac Cardiovasc Surg. 2013 Aug;146(2):472-8. doi: 10.1016/j.jtcvs.2013.02.075. Epub 2013 Mar 28.

18.

Epidemiology of deep sternal wound infection in cardiac surgery.

Filsoufi F, Castillo JG, Rahmanian PB, Broumand SR, Silvay G, Carpentier A, Adams DH.

J Cardiothorac Vasc Anesth. 2009 Aug;23(4):488-94. doi: 10.1053/j.jvca.2009.02.007. Epub 2009 Apr 19.

PMID:
19376733
19.

Adverse impact of surgical site infections in English hospitals.

Coello R, Charlett A, Wilson J, Ward V, Pearson A, Borriello P.

J Hosp Infect. 2005 Jun;60(2):93-103.

PMID:
15866006
20.

Gender risk differences for surgical site infections among a primary coronary artery bypass graft surgery cohort: 1995-1998.

Bundy JK, Gonzalez VR, Barnard BM, Hardy RJ, DuPont HL.

Am J Infect Control. 2006 Apr;34(3):114-21.

PMID:
16630973
Items per page

Supplemental Content

Write to the Help Desk